Prostate tumor cell plasticity: A consequence of the microenvironment

Advances in Experimental Medicine and Biology

Volumn 720, Issue , 2011, Pages 81-90

  Yates, Clayton ^a  

^a TUSKEGEE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TUMOR MARKER; UVOMORULIN; MICRORNA; MONOCLONAL ANTIBODY;

CELL ADHESION; CELL INTERACTION; CONFERENCE PAPER; DISEASE ASSOCIATION; E CADHERIN GENE; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE EXPRESSION REGULATION; HUMAN; INTRACELLULAR SIGNALING; METASTASIS; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; STROMA CELL; TARGET CELL; TREATMENT PLANNING; TUMOR MICROENVIRONMENT; ARTICLE; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER RELAPSE; CELL MIGRATION; CELL SURVIVAL; DRUG EFFICACY; MOLECULARLY TARGETED THERAPY; PHENOTYPIC VARIATION; TUMOR SEEDING; MALE; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; REVIEW;

CELL ADHESION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MALE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; STROMAL CELLS; TUMOR MICROENVIRONMENT;

EID: 80053920605     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-0254-1_7     Document Type: Conference Paper

References (45)

1. Kahn LB, Uys CJ, Dale J, Rutherfoord S (1978) Carcinoma of the breast with metaplasia to chondrosarcoma: a light and electron microscopic study. Histopathology 2:93-106 (Pubitemid 8327683)
2. Hay ED, Zuk A (1995) Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. Am J Kidney Dis 26:678-690
3. Ehrlich JS, Hansen MD, Nelson WJ (2002) Spatiotemporal regulation of Rac1 localization and lamellipodia dynamics during epithelial cell-cell adhesion. Dev Cell 3:259-270
4. Akhtar N, Hudson KR, Hotchin NA (2000) Co-localization of Rac1 and E-cadherin in human epidermal keratinocytes. Cell Adhes Commun 7: 465-476
5. Ray ME, Mehra R, Sandler HM, Daignault S, Shah RB (2006) E-cadherin protein expression predicts prostate cancer salvage radiotherapy outcomes. J Urol 176:1409-1414, discussion 14 (Pubitemid 44307202)
6. Hennig G, Behrens J, Truss M, Frisch S, Reichmann E, Birchmeier W (1995) Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene 11:475-484
7. Graff JR, Herman JG, Lapidus RG et al (1995) E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55:5195-5199
8. Machado JC, Oliveira C, Carvalho R et al (2001) E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 20:1525-1528 (Pubitemid 32291203)
9. Berx G, Becker KF, Hofler H, van Roy F (1998) Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 12:226-237 (Pubitemid 28418891)
10. Hirohashi S (1998) Inactivation of the E-cadherinmediated cell adhesion system in human cancers. Am J Pathol 153:333-339 (Pubitemid 28373643)
11. Jennbacken K, Tesan T, Wang W, Gustavsson H, Damber JE, Welen K (2010) N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer. Endocr Relat Cancer 17:469-479
12. Tanaka H, Kono E, Tran CP et al (2010) Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nat Med 16:1414-1420
13. Tran NL, Nagle RB, Cress AE, Heimark RL (1999) N-cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion with stromal cells. Am J Pathol 155:787-798 (Pubitemid 29426824)
14. Odero-Marah VA, Wang R, Chu G et al (2008) Receptor activator of NF-kappaB ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells. Cell Res 18:858-870
15. Liu J, Uygur B, Zhang Z et al (2010) Slug inhibits proliferation of human prostate cancer cells via downregulation of cyclin D1 expression. Prostate 70: 1768-1777
16. Emadi Baygi M, Soheili ZS, Schmitz I, Sameie S, Schulz WA (2010) Snail regulates cell survival and inhibits cellular senescence in human metastatic prostate cancer cell lines. Cell Biol Toxicol 26:553-567
17. Kwok WK, Ling MT, Lee TW et al (2005) Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res 65: 5153-5162 (Pubitemid 40827324)
18. Yuen HF, Chan YP, Wong ML et al (2007) Upregulation of twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis. J Clin Pathol 60:510-514 (Pubitemid 46867160)
19. Downing JR, Reynolds AB (1991) PDGF, CSF-1, and EGF induce tyrosine phosphorylation of p120, a pp 60src transformation-associated substrate. Oncogene 6:607-613 (Pubitemid 21924126)
20. Hazan RB, Norton L (1998) The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton. J Biol Chem 273: 9078-9084 (Pubitemid 28176196)
21. Andl CD, Mizushima T, Nakagawa H et al (2003) Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. J Biol Chem 278:1824-1830 (Pubitemid 36801419)
22. Kassis J, Moellinger J, Lo H, Greenberg NM, Kim HG, Wells A (1999) A role for phospholipase C-gammamediated signaling in tumor cell invasion. Clin Cancer Res 5:2251-2260 (Pubitemid 29399285)
23. Nakashiro K, Okamoto M, Hayashi Y, Oyasu R (2000) Hepatocyte growth factor secreted by prostate-derived stromal cells stimulates growth of androgen-independent human prostatic carcinoma cells. Am J Pathol 157: 795-803 (Pubitemid 32109372)
24. Yates C, Wells A, Turner T (2005) Luteinising hormone- releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline. Br J Cancer 92:366-375 (Pubitemid 40343154)
25. Davies G, Jiang WG, Mason MD (2001) HGF/SF modifies the interaction between its receptor c-Met, and the E-cadherin/catenin complex in prostate cancer cells. Int J Mol Med 7:385-388
26. Josson S, Anderson CS, Sung SY et al (2011) Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy. Prostate 71(3):232-240
27. Graham TR, Zhau HE, Odero-Marah VA et al (2008) Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res 68: 2479-2488 (Pubitemid 351521824)
28. Yates C, Shepard CR, Papworth G et al (2007) Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression. Adv Cancer Res 97:225-246 (Pubitemid 46528990)
29. Yates CC, Shepard CR, Stolz DB, Wells A (2007) Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer 96:1246-1252 (Pubitemid 46625074)
30. Li LC, Zhao H, Nakajima K et al (2001) Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer. J Urol 166:705-709 (Pubitemid 32652304)
31. Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA- 10b in breast cancer. Nature 449:682-688 (Pubitemid 47552092)
32. Lehmann U, Hasemeier B, Christgen M et al (2008) Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 214:17-24
33. Dalmay T, Edwards DR (2006) MicroRNAs and the hallmarks of cancer. Oncogene 25:6170-6175 (Pubitemid 44527847)
34. Kong D, Li Y, Wang Z et al (2009) miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells 27:1712-1721
35. Wu TT, Sikes RA, Cui Q et al (1998) Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigenproducing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer 77:887-894 (Pubitemid 28378138)
36. Zhau HE, Li CL, Chung LW (2000) Establishment of human prostate carcinoma skeletal metastasis models. Cancer 88:2995-3001 (Pubitemid 30413182)
37. Paget S (1889) The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev 8:98-101
38. Chung LW (2003) Prostate carcinoma bone-stroma interaction and its biologic and therapeutic implications. Cancer 97:772-778 (Pubitemid 36125812)
39. Stessels F, Van den Eynden G, Van der Auwera I et al (2004) Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia. Br J Cancer 90:1429-1436 (Pubitemid 38586273)
40. Buijs JT, Rentsch CA, van der Horst G et al (2007) BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. Am J Pathol 171: 1047-1057 (Pubitemid 47441001)
41. Morrissey C, True LD, Roudier MP et al (2008) Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases. Clin Exp Metastasis 25:377-388
42. Josson S, Sharp S, Sung SY (2010) et al. Tumorstromal interactions influence radiation sensitivity in epithelial - versus mesenchymal-like prostate cancer cells, J Oncol
43. Saha B, Kaur P, Tsao-Wei D et al (2008) Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone. Prostate 68:1681-1688
44. Green SK, Karlsson MC, Ravetch JV, Kerbel RS (2002) Disruption of cell-cell adhesion enhances antibody-dependent cellular cytotoxicity: implications for antibody-based therapeutics of cancer. Cancer Res 62:6891-6900 (Pubitemid 35424078)
45. Lamb LE, Knudsen BS, Miranti CK (2010) E-cadherin-mediated survival of androgen-receptorexpressing secretory prostate epithelial cells derived from a stratified in vitro differentiation model. J Cell Sci 123:266-276